Lyon Hepatology Institute
The Lyon Hepatology Institute (IHL) was created with the mission to meet the current challenges of chronic liver diseases by providing a scientific environment in which basic, translational and clinical research are integrated for the benefit of patients.
Mission/objectives:
- To coordinate the communication between clinicians and scientists in order to identify unmet medical needs and improve current diagnostic and therapeutic options.
- To facilitate the exchange of clinical samples and data with the aim to better understand disease biology and identify new clinical markers and therapeutic strategies.
- To accelerate the transition of innovative scientific developments into clinical evaluation.
- To provide scientific training for the next generation of physician/scientists aiming to become leaders in the field of hepatology.
- To improve patient access to scientific information, medical care and individualized therapies in order to achieve a sustainable precision medicine for all.
Lyon hepatology Institute
in figures
Research
teams
Scientists
researchers
Clinical
units
Clinicians
Make a donation is above all
speeding up research
Our research fields
With liver pathologies on the rise, the Lyon Hepatology Institute works to better detect and combat all diseases affecting this organ.
The institute’s research is structured around 6 axes:
Liver transplantation
End-stage liver disease
Hepatocellular carcinoma
Addiction and the liver
Liver Metabolism – MASLD
Viral Liver Disease
Our news
- August 2024
- Uncategorized
First IHU Internal call for proposals
First IHU internal call for proposals We are delighted to announce the launch of the first for proposals of the Lyon Hepatology Institute. Applications must be submitted by IHU members, and are due by October 1, 2024. Projects will be evaluated by our International Scientific Advisory Board (SAB). The results will be known at the […]
- July 2024
- Évènement
IHU EVEREST Kick-off meeting
Official launch of the Lyon Hepatology Institute from left to right:F. Lacoste (VP public health Institut Mérieux), F. Zoulim (IHU Director), D. Samuel (Inserm CEO), C. Staron (VP ESRI – Région AuRA), G. Fioni (Delegate rector), R. Le Moign (HCL General Manager), F. Fleury (UCBL President ) July 9, 2024 marked the official launch of […]